UnitedHealth Group Incorporated $UNH Shares Sold by Martingale Asset Management L P

Key Points

• Martingale Asset Management reduced its stake in UnitedHealth Group by 10.2%, now owning 72,374 shares valued at approximately $37.9 million, making it the 20th largest holding in their portfolio.
• UnitedHealth Group's quarterly earnings fell short of analysts' expectations, reporting $4.08 earnings per share compared to the estimated $4.45, despite a revenue increase of 12.9% year-over-year.
• The company announced a quarterly dividend of $2.21 per share, with a dividend yield of 2.9%, set to be paid on September 23rd, 2023.

Martingale Asset Management L P trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 10.2% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 72,374 shares of the healthcare conglomerate's stock after selling 8,231 shares during the quarter. UnitedHealth Group accounts for approximately 1.0% of Martingale Asset Management L P's portfolio, making the stock its 20th largest holding. Martingale Asset Management L P's holdings in UnitedHealth Group were worth $37,906,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at approximately $26,000. Bayforest Capital Ltd increased its stake in UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after purchasing an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd boosted its position in UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after purchasing an additional 50 shares in the last quarter. IAG Wealth Partners LLC purchased a new position in shares of UnitedHealth Group in the first quarter valued at $42,000. Finally, Kapitalo Investimentos Ltda purchased a new position in UnitedHealth Group during the 4th quarter valued at about $41,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer owned 10,398 shares in the company, valued at $3,171,390. This trade represents a 5.36% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.28% of the company's stock.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH opened at $299.8310 on Thursday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The firm has a market capitalization of $271.55 billion, a PE ratio of 12.99, a P/E/G ratio of 1.96 and a beta of 0.43. The business has a 50-day moving average of $288.81 and a two-hundred day moving average of $392.90.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same period last year, the firm earned $6.80 earnings per share. The company's quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be paid a dividend of $2.21 per share. The ex-dividend date is Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.9%. UnitedHealth Group's dividend payout ratio (DPR) is currently 38.30%.

Analyst Upgrades and Downgrades

A number of brokerages have commented on UNH. Royal Bank Of Canada lowered their target price on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a report on Wednesday, July 30th. Robert W. Baird reissued an "underperform" rating and issued a $198.00 price objective (down previously from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Bank of America boosted their price target on UnitedHealth Group from $290.00 to $325.00 and gave the company a "neutral" rating in a report on Monday. Deutsche Bank Aktiengesellschaft lowered their price objective on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a research report on Wednesday, May 14th. Finally, KeyCorp decreased their price target on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 30th. Fifteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and an average price target of $365.38.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.